Timothy Lin

17PUBLICATIONS

48CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Probability theoryAdversarial machine learningPredictive and prognostic markersApplied statistics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 04, 2026

TRIPLETE But Incomplete? Accounting for Post-Progression Therapy When Interpreting Overall Survival.

|May 01, 2026

Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.

|Jul 03, 2025

Generative AI in Medicine: Pioneering Progress or Perpetuating Historical Inaccuracies? Cross-Sectional Study Evaluating Implicit Bias.

Philip Sutera, Rohini Bhatia, Timothy Lin

|Jan 27, 2025

Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.

Alexander D Sherry, Yufei Liu, Pavlos Msaouel

|Jan 08, 2025

Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.

Avital M Miller, Adina H Passy, Alexander D Sherry

|Dec 10, 2024

Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study.

Troy J Kleber, Alexander D Sherry, Andrew J Arifin

Pageof 3

Frequent Collaborators

14 joint publications

Ethan B Ludmir

11 joint publications

Alexander D Sherry

10 joint publications

Ramez Kouzy

Pavlos Msaouel

Zachary R McCaw

Joseph Abi Jaoude

Avital M Miller